+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of HCV/HIV coinfection with leukocyte derived interferon alfa-n3



Treatment of HCV/HIV coinfection with leukocyte derived interferon alfa-n3



Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148




(PDF emailed within 0-6 h: $19.90)

Accession: 035980450

Download citation: RISBibTeXText

DOI: 10.1016/S0016-5085(00)81854-5


Related references

The retreatment with natural leukocyte interferon alfa-n3 of chronic hepatitis C patients: the intolerant and nonresponsive results to prior treatment with recombinant alfa interferon. Annali Italiani di Medicina Interna 14(3): 159-165, 1999

The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection. Viral Immunology 25(2): 166-172, 2012

Human leukocyte interferon alfa therapy in a patient with thrombocytosis and antibodies to previous recombinant interferon alpha-2a treatment. Journal of Interferon Research 12(SUPPL 1): S163, 1992

Management of condylomata acuminata with Alferon N injection, interferon alfa-n3 (human leukocyte derived). American Journal of Obstetrics and Gynecology 172(4 Pt 2): 1359-1368, 1995

Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides. Journal of Biological Regulators and Homeostatic Agents 1(2): 93-99, 1987

Sequence analysis of hepatitis C virus subtype 1b NS5A gene segment from patients treated with human leukocyte-derived interferon alfa-N3. Hepatology 26(4 PART 2): 307A, 1997

Non a non b chronic hepatitis not responding to a standard interferon alfa treatment doubling interferon alfa dosage has marginal efficacy. Journal of Hepatology 13(SUPPL 2): S77, 1991

Safety and efficacy of interferon-alfa and interferon-alfa plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients under HAART. Hepatology 32(4 Pt 2): 555A, 2000

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34(2): 395-403, 2001

A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C. Gastroenterologia Y Hepatologia 18(2): 66-72, 1995

Alfa interferon 2B and ribavirin for treatment of patients with chronic hepatitis C who have failed alfa interferon 2B as single therapy. Hepatology 28(4 PART 2): 284A, 1998

A randomized, double blind, placebo controlled trial of interferon-alfa and amantadine versus interferon-alfa alone in the treatment of chronic hepatitis C. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148, 2000

Ribavirin plus alfa interferon in the treatment of chronic hepatitis C unresponsive to alfa interferon alone Evaluation of response in terms of ALT values and quantitative viraemia. Hepatology 24(4 PART 2): 483A, 1996

A randomized study of Ribavirin plus interferon alfa vs interferon alfa alone for treatment of patients with chronic hepatitis C. Hepatology 30(4 PART 2): 621A, 1999

Natural alfa interferon treatment of chronic hepatitis C in patients refractory to recombinant interferon alfa 2B. Hepatology 22(4 PART 2): 117A, 1995